Active ingredient
Epoetin Alfa
26 finished FDA listings contain Epoetin Alfa as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- EPOETIN
- Dosage forms
- Injection, Solution, Solution
- Routes
- Intravenous, Subcutaneous
- Manufacturers / labelers
- 4
- Strengths listed
- 10000 [iu]/ml · 2000 [iu]/ml · 20000 [iu]/ml · 3000 [iu]/ml · 4000 [iu]/ml · 40000 [iu]/ml
- Brand names in FDA listings
- Epogen, Procrit, Retacrit
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 105694
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 103234 | AMGEN | 1989-06-01 | 13 |
| BLA 125545 | HOSPIRA INC | 2018-05-15 | 13 |
Official labeling on DailyMed
- EPOGEN (EPOETIN ALFA) SOLUTION [AMGEN, INC] · version 137 · 2026-07-01
- RETACRIT (EPOETIN ALFA-EPBX) INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] · version 19 · 2025-06-26
- RETACRIT (EPOETIN ALFA-EPBX) INJECTION, SOLUTION [VIFOR (INTERNATIONAL) INC.] · version 14 · 2025-06-26
- PROCRIT (ERYTHROPOIETIN) INJECTION, SOLUTION [JANSSEN PRODUCTS, LP] · version 31 · 2025-04-10
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.